Idéal Investisseur
Français English
CAC 40 :
8 157,82 pts
-0.84%


Last updated : 24/04/2026 - 17h35 (last close)
Last close data
🏠 Home   ➤    Stock news

Emeis Finalizes a 3.15 Billion Euro Refinancing and Anticipates Exiting the Accelerated Safeguard Plan

On December 18, the healthcare group Emeis announced that it had finalized the raising of 3.15 billion euros in new financing from banks and financial investors. This operation allows for the early repayment of old bank debt and is expected to lead to an early exit from the accelerated safeguard plan.


Emeis Finalizes a 3.15 Billion Euro Refinancing and Anticipates Exiting the Accelerated Safeguard Plan

Details of the New Financing

According to the press release, the new financing is divided into three distinct tranches. The first consists of a term loan of 2.2 billion euros with a maturity of 6 years, featuring staggered amortizations between December 2028 and December 2030. The second tranche corresponds to a listed bond issue of 400 million euros, placed with qualified investors and also with a maturity of 6 years. Finally, the third tranche includes 550 million euros in loans, of which 350 million euros are a term loan drawn immediately with a due date at the end of June 2030, and 200 million euros are revolving credit lines available from January 2027. According to the company, the average maturity of these financings is 5.5 years with an average margin over Euribor of 247 basis points. The group indicates that these funds have enabled the repayment of old loans with a residual balance of approximately 2.9 billion euros as of the end of October 2025.

Strict Contractual Commitments Accompanying the Refinancing

Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
Before 9 AM every morning Euronext data AI-powered analysis

The refinancing comes with strict contractual commitments, the press release specifies. The group must respect a leverage ratio ranging from 12.0 times at the end of 2026 to 6.5 times from the end of 2029. Investments are also capped at approximately 375 million euros per year on average, with a maximum of 130 million euros for development investments alone. Regarding the 400 million euro bond tranche, it has a margin of 475 basis points over the 3-month Euribor. According to the company, the placement has significantly diversified the investor base, with allocations ranging from 72% to 100%. The financings include clauses for mandatory early repayment in the event of a change of control or asset sales beyond determined thresholds. However, the group may distribute dividends in the future if the leverage ratio is below 7.5 times, up to 40% of the net consolidated profit of the concerned fiscal year.

Early Repayment of Old Loans to Facilitate Exiting the Accelerated Safeguard Plan

The repayment of old loans will allow the group to request an early exit from the accelerated safeguard plan, the press release indicates. A request will be filed with the Nanterre Economic Affairs Court in the coming weeks. This operation occurs more than a year ahead of the initially planned schedule. Additionally, the finalization of the agreement also lifts the main suspensive condition related to the real estate project announced on September 23, 2025, which should enable the group to reduce its debt by approximately 700 million euros. The closing of this operation is expected at the beginning of 2026. According to Laurent Guillot, CEO of Emeis, this operation marks a major step in the restructuring of the group and sustainably strengthens its financial structure. The refinancing increases the average maturity of the debt by 2.5 years, now bringing it to nearly 5 years.



Sector Santé · Etablissements de santé / EHPAD Etablissements de santé


Assurance vie

Context

Period
  • Period: 9M 2025
Guidance from the release
  • Croissance organique soutenue (+6,4% à fin septembre 2025, +7,0% au T3), amélioration notable des taux d'occupation, objectifs de cessions dépassés (2,1 Md€) et confirmation des perspectives 2025 et de la trajectoire 2024-2028.
Risks mentioned
  • Risques et incertitudes liés aux conditions de marché futures pouvant affecter les résultats prévisionnels
  • Risque de non-réalisation ou de délai des cessions actuellement sécurisées ou en négociation
  • Impact transitoire des ouvertures récentes sur les taux d'occupation dans certaines zones
Opportunities identified
  • Croissance démographique des plus de 75 ans (+30% d'ici 10 ans) créant une demande structurelle accrue
  • Déficit structurel d'offre (déficit attendu de lits sur principaux marchés) offrant une forte visibilité commerciale
  • Possibilités de capture d'effets prix favorables et d'amélioration de marges opérationnelles

The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.

Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.

Advertisement
Every morning
Technical market signals,
before the opening bell.
CAC 40 · SBF 120 · Signals · Analysts
🤖
Today's edition — pre-market
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Bullish signals
+5,2%
+1,8%
+0,9%
📉 Bearish signals
-14%
-5,7%
🔄 Analyst opinions
▲ 35 €
▼ 80 €
Sign up to see everything →
Before 9 AM every morning
Euronext data
AI-powered analysis





BOURSE · Chaque matin
La synthèse bourse,
avant l'ouverture.
Notre moteur analyse chaque nuit le CAC 40 et le SBF 120. Ce qui mérite attention remonte directement dans votre boîte mail. Gratuit.
Avant 9h00 1000+ inscrits 100% gratuit